Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
A Cancerous Crossroad: Invasive Adenocarcinoma With Multiple Enteric Fistulae.
Journal: The American journal of gastroenterology
Published: February 27, 2025
ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab.
Journal: Journal of hepatocellular carcinoma
Published: February 03, 2024
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.
Journal: Hepatology (Baltimore, Md.)
Published: January 29, 2024
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: September 19, 2023
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
Journal: Journal of hepatology
Published: August 29, 2023
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.
Journal: Hepatology communications
Published: April 27, 2023
Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study.
Journal: Hepatology communications
Published: November 11, 2022
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
Journal: Cancers
Published: November 01, 2022
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: June 28, 2022
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 17, 2022
Last Updated: 09/26/2026